Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $83,394 - $92,791
399 Added 0.73%
55,124 $12 Million
Q4 2023

Feb 06, 2024

BUY
$197.69 - $227.29 $8,302 - $9,546
42 Added 0.08%
54,725 $12.4 Million
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $47,045 - $51,877
-234 Reduced 0.43%
54,683 $11 Million
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $230,791 - $262,808
-1,089 Reduced 1.94%
54,917 $13.3 Million
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $81,701 - $98,748
383 Added 0.69%
56,006 $12.8 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $39,725 - $48,549
-195 Reduced 0.35%
55,623 $13.1 Million
Q3 2022

Oct 21, 2022

BUY
$204.81 - $262.19 $154,221 - $197,429
753 Added 1.37%
55,818 $11.4 Million
Q2 2022

Aug 09, 2022

SELL
$213.86 - $277.87 $120,403 - $156,440
-563 Reduced 1.01%
55,065 $12.9 Million
Q1 2022

Apr 29, 2022

SELL
$259.82 - $298.18 $61,057 - $70,072
-235 Reduced 0.42%
55,628 $17.5 Million
Q4 2021

Jan 20, 2022

BUY
$271.6 - $314.21 $350,907 - $405,959
1,292 Added 2.37%
55,863 $17.6 Million
Q3 2021

Oct 27, 2021

BUY
$274.82 - $308.34 $752,731 - $844,543
2,739 Added 5.28%
54,571 $15.4 Million
Q2 2021

Jul 28, 2021

BUY
$251.87 - $278.14 $70,523 - $77,879
280 Added 0.54%
51,832 $14.3 Million
Q1 2021

Apr 22, 2021

BUY
$204.88 - $255.03 $63,512 - $79,059
310 Added 0.6%
51,552 $13.1 Million
Q4 2020

Jan 19, 2021

BUY
$186.91 - $214.42 $484,470 - $555,776
2,592 Added 5.33%
51,242 $10.4 Million
Q3 2020

Nov 03, 2020

BUY
$167.03 - $201.3 $304,996 - $367,573
1,826 Added 3.9%
48,650 $9.16 Million
Q2 2020

Jul 09, 2020

BUY
$113.31 - $182.44 $609,721 - $981,709
5,381 Added 12.98%
46,824 $7.78 Million
Q1 2020

Apr 08, 2020

BUY
$104.32 - $195.28 $145,630 - $272,610
1,396 Added 3.49%
41,443 $5.24 Million
Q4 2019

Jan 10, 2020

BUY
$163.48 - $173.61 $453,657 - $481,767
2,775 Added 7.45%
40,047 $6.78 Million
Q3 2019

Oct 09, 2019

BUY
$159.77 - $178.1 $483,144 - $538,574
3,024 Added 8.83%
37,272 $6.26 Million
Q2 2019

Jul 16, 2019

BUY
$144.16 - $172.9 $277,508 - $332,832
1,925 Added 5.96%
34,248 $5.92 Million
Q1 2019

Apr 08, 2019

BUY
$123.7 - $156.3 $26,842 - $33,917
217 Added 0.68%
32,323 $4.95 Million
Q4 2018

Jan 24, 2019

BUY
$120.82 - $174.09 $42,287 - $60,931
350 Added 1.1%
32,106 $4.06 Million
Q3 2018

Oct 16, 2018

BUY
$167.67 - $188.27 $151,741 - $170,384
905 Added 2.93%
31,756 $5.52 Million
Q2 2018

Jul 13, 2018

BUY
$160.33 - $189.41 $66,536 - $78,605
415 Added 1.36%
30,851 $5.54 Million
Q1 2018

Apr 17, 2018

BUY
$161.53 - $178.11 $36,344 - $40,074
225 Added 0.74%
30,436 $4.92 Million
Q4 2017

Jan 22, 2018

BUY
$147.99 - $163.95 $28,118 - $31,150
190 Added 0.63%
30,211 $4.82 Million
Q3 2017

Oct 11, 2017

BUY
$149.47 - $160.56 $4.49 Million - $4.82 Million
30,021
30,021 $4.53 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Forte Capital LLC Portfolio

Follow Forte Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.